Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000186797 | SCV000240366 | uncertain significance | not provided | 2015-12-22 | criteria provided, single submitter | clinical testing | p.Thr757Thr (T757T) ACG>ACA: c.2271 G>A in exon 16 of the ATP1A2 gene (NM_000702.3). The c.2271 G>A nucleotide substitution has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. Multiple in-silico algorithms predict that the c.2271 G>A substitution could potentially create a new cryptic acceptor site that may supplant the natural site in exon 16 and lead to abnormal splicing. However, in the absence of RNA/functional and clinical studies, the actual effect of the c.2271 G>A sequence change is unknown. The variant is found in EPILEPSY panel(s). |
Labcorp Genetics |
RCV001857603 | SCV002194195 | likely benign | Familial hemiplegic migraine | 2025-01-08 | criteria provided, single submitter | clinical testing |